372
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

The safety of concurrent intrathecal chemotherapy during blinatumomab in adults with acute lymphoblastic leukemia

, , , ORCID Icon, ORCID Icon & ORCID Icon
Pages 2754-2756 | Received 18 May 2022, Accepted 13 Jun 2022, Published online: 21 Jun 2022
 

Disclosure statement

Ibrahim Aldoss and Vinod Pullarkat has received consulting fees and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for Amgen Inc from Amgen Inc. Anthony Stein has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for Amgen Inc. The other authors report there are no competing interests to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.